难治性哮喘合并肥胖的1年体重管理项目:随机对照研究
本研究为单中心随机对照试验,纳入36例难治性哮喘且BMI≥30 kg/m2的成人,比较Counterweight-Plus项目(CWP)与常规护理(UC)1年哮喘结局;52周时CWP组体重下降更显著,达到AQLQ最小临床重要差异的比例更高,但ACQ-6组间无差异。
核心结论
- 由营养师支持的体重管理项目带来持续减重,可能成为哮喘合并肥胖的治疗选择。
- CWP组达到AQLQ的MCID比例高于UC组,组内AQLQ与急性发作频率变化提示CWP潜力。
研究设计与样本
- 单中心随机对照试验,纳入难治性哮喘且BMI≥30 kg/m2的成人,按1:1随机分为CWP组与UC组。
- 共招募36例,52周时29例完成随访(CWP组13例,UC组16例)。
关键数值与推荐
- ACQ-6与AQLQ的最小临床重要差异(MCID)均为0.5。
- CWP包括12周全饮食替代阶段(850 kcal/d低能量配方),随后食物再引入与维持阶段至1年。
临床怎么用
- 对难治性哮喘合并肥胖患者,可考虑由营养师支持的体重管理项目以改善体重与生活质量。
- 减重≥10%与ACQ-6及AQLQ改善相关,可作为临床关注目标。
局限性
- 样本量小(招募36例,52周随访29例),结果需更大样本研究验证。
- ACQ-6组间无差异,急性发作频率组间亦无差异,哮喘相关结局证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity-associated asthma results in increased morbidity and mortality. We report 1-year asthma outcomes with a weight management regimen, the Counterweight-Plus Programme (CWP), compared with usual care (UC) in a single-center, randomized controlled trial in patients with difficult-to-treat asthma and obesity. RESEARCH QUESTION: Can use of the CWP result in improved asthma control and quality of life compared with UC at 1 year in patients with difficult-to-treat asthma and obesity? STUDY DESIGN AND METHODS: Adults with difficult-to-treat asthma and BMI ≥ 30 kg/m2 were randomized (1:1 CWP:UC) to treatment. The CWP, with dietitian support, included a 12-week total diet replacement phase (850 kcal/d low-energy formula), and then subsequent food reintroduction and maintenance phases up to 1 year. Outcomes include results of the six-item Asthma Control Questionnaire (ACQ-6) and Asthma Quality of Life Questionnaire (AQLQ), as well as health care usage. A minimal clinically important difference (MCID) is 0.5 for ACQ-6 and AQLQ. RESULTS: Of 36 patients recruited, 29 attended visits at 52 weeks (13 CWP and 16 UC). The CWP resulted in greater weight change (median, -14 kg [interquartile range (IQR), -15 to -9 kg]) compared with UC (median, 2 kg [IQR, -7 to 8 kg]; P = .015) at 52 weeks. A greater proportion achieved MCID with the CWP vs UC in AQLQ (71% vs 6%, respectively; P < .001). No between-group differences were observed in ACQ-6. Median exacerbation frequency was reduced over 52 weeks with the CWP from 4 (IQR, 2 to 5) to 0 (IQR, 0 to 2) (P < .001), although no between-group difference was observed. Seventy percent of the CWP group lost ≥ 10% body weight and had improvement in ACQ-6 (mean difference, -1.1; 95% CI, -1.9 to -0.3; P = .018) and AQLQ (mean difference, 1.2; 95% CI, 0.4, 2.1; P = .011) across 52 weeks. INTERPRETATION: In this study, the use of a dietitian-supported weight management program resulted in sustained weight loss and is a potential treatment for obesity in asthma. The CWP resulted in a higher proportion achieving MCID improvements in AQLQ compared with UC. Within-group differences in AQLQ and exacerbation frequency suggest potential with the CWP. These encouraging signals justify a larger sample study to further assess asthma-related outcomes.
引用
- Sharma, Ricketts, McCombie, et al. A 1-Year Weight Management Program for Difficult-to-Treat Asthma With Obesity: A Randomized Controlled Study. Chest. 2024. PMID: 39427706. doi:10.1016/j.chest.2024.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。